Cargando…

Size and PEG Length-Controlled PEGylated Monocrystalline Superparamagnetic Iron Oxide Nanocomposite for MRI Contrast Agent

OBJECTIVE: PEGylated superparamagnetic iron oxide (SPIO) is the most promising alternatives to gadolinium-based contrast agents (GBCAs) in MRI. This paper is to explore the imaging effects of PEGylated SPIO, which is influenced by particle sizes and surface polyethylene glycol (PEG) coating, using a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Li-Hua, Jiang, Hai, Lu, Fu-Lin, Wang, Han-Wei, Pu, Yu, Wu, Chang-Qiang, Tang, Hong-Jie, Xu, Ye, Chen, Tian-Wu, Zhu, Jiang, Shen, Cheng-Yi, Zhang, Xiao-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802780/ https://www.ncbi.nlm.nih.gov/pubmed/33447035 http://dx.doi.org/10.2147/IJN.S271461

Ejemplares similares

PEGylation of Superparamagnetic Iron Oxide Nanoparticles with Self-Organizing Polyacrylate-PEG Brushes for Contrast Enhancement in MRI Diagnosis
por: Illés, Erzsébet, et al.
Publicado: (2018)

Superparamagnetic Iron Oxide Nanoparticles as MRI contrast agents for Non-invasive Stem Cell Labeling and Tracking
por: Li, Li, et al.
Publicado: (2013)

Effects of PEG Chain Length on Relaxometric Properties of Iron Oxide Nanoparticles-Based MRI Contrast Agent
por: Ge, Jianxian, et al.
Publicado: (2022)

Preparation and characterization of peptide modified ultrasmall superparamagnetic iron oxides used as tumor targeting MRI contrast agent
por: Yin, Jie, et al.
Publicado: (2019)

New MRI contrast agents based on silicon nanotubes loaded with superparamagnetic iron oxide nanoparticles
por: Gonzalez-Rodriguez, Roberto, et al.
Publicado: (2018)

Polymer-coated superparamagnetic iron oxide nanoparticles as T(2) contrast agent for MRI and their uptake in liver
por: Ali, Lamiaa MA, et al.
Publicado: (2017)

Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agents
por: Di Marco, Mariagrazia, et al.
Publicado: (2007)

Mn(ii) chelate-coated superparamagnetic iron oxide nanocrystals as high-efficiency magnetic resonance imaging contrast agents
por: Wu, Changqiang, et al.
Publicado: (2020)

Ultrasmall cationic superparamagnetic iron oxide nanoparticles as nontoxic and efficient MRI contrast agent and magnetic-targeting tool
por: Uchiyama, Mayara Klimuk, et al.
Publicado: (2015)

In situ self-assembly of amphiphilic dextran micelles and superparamagnetic iron oxide nanoparticle-loading as magnetic resonance imaging contrast agents
por: Jiang, Linrui, et al.
Publicado: (2022)

T(1)–T(2) Dual-modal MRI contrast agents based on superparamagnetic iron oxide nanoparticles with surface attached gadolinium complexes
por: Szpak, Agnieszka, et al.
Publicado: (2014)

Bisphosphonate-Anchored PEGylation and Radiolabeling of Superparamagnetic Iron Oxide: Long-Circulating Nanoparticles for in Vivo Multimodal (T1 MRI-SPECT) Imaging
por: Sandiford, Lydia, et al.
Publicado: (2012)

Size-isolation of superparamagnetic iron oxide nanoparticles improves MRI, MPI and hyperthermia performance
por: Dadfar, Seyed Mohammadali, et al.
Publicado: (2020)

Labeling Efficacy of Superparamagnetic Iron Oxide Nanoparticles to Human Neural Stem Cells: Comparison of Ferumoxides, Monocrystalline Iron Oxide, Cross-linked Iron Oxide (CLIO)-NH(2) and tat-CLIO
por: Song, Miyeoun, et al.
Publicado: (2007)

Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging
por: Unterweger, Harald, et al.
Publicado: (2017)

Exploring atherosclerosis imaging with contrast-enhanced MRI using PEGylated ultrasmall iron oxide nanoparticles
por: Zhang, Ruru, et al.
Publicado: (2023)

Superparamagnetic Bifunctional Bisphosphonates Nanoparticles: A Potential MRI Contrast Agent for Osteoporosis Therapy and Diagnostic
por: Lalatonne, Y., et al.
Publicado: (2010)

Monoclonal antibody A7-superparamagnetic iron oxide as contrast agent of MR imaging of rectal carcinoma
por: Toma, A, et al.
Publicado: (2005)

Superparamagnetic iron oxide-C595: Potential MR imaging contrast agents for ovarian cancer detection
por: Shahbazi-Gahrouei, Daryoush, et al.
Publicado: (2013)

The Impact of PEGylation on Cellular Uptake and In Vivo Biodistribution of Gold Nanoparticle MRI Contrast Agents
por: El-Baz, Nagwa, et al.
Publicado: (2022)

Safety of PEGylated recombinant human full‐length coagulation factor VIII (BAX 855) in the overall context of PEG and PEG conjugates
por: Stidl, R., et al.
Publicado: (2015)

Enhanced MRI T(2) Relaxivity in Contrast-Probed Anchor-Free PEGylated Iron Oxide Nanoparticles
por: Thapa, Bibek, et al.
Publicado: (2017)

PEG-Grafted Graphene/PLLA Nanocomposites: Effect of PEG Chain Length on Crystallization Kinetics of PLLA
por: Karimi, Samira, et al.
Publicado: (2022)

Self-Assembled Superparamagnetic Iron Oxide Nanoclusters for Universal Cell Labeling and MRI
por: Chen, Shuzhen, et al.
Publicado: (2016)

Improving the Size Homogeneity of Multicore Superparamagnetic Iron Oxide Nanoparticles
por: Yeh, Barry J., et al.
Publicado: (2020)

Ultra-small superparamagnetic iron oxide contrast agents for lymph node staging of high-risk prostate cancer
por: Czarniecki, Marcin, et al.
Publicado: (2018)

Erratum: Superparamagnetic Iron Oxide-C595: Potential MR Imaging Contrast Agents for Ovarian Cancer Detection
Publicado: (2020)

PEG-Coated MnZn Ferrite Nanoparticles with Hierarchical Structure as MRI Contrast Agent
por: Cheraghali, Sedigheh, et al.
Publicado: (2023)

Nanovectors for anticancer agents based on superparamagnetic iron oxide nanoparticles
por: Douziech-Eyrolles, Laurence, et al.
Publicado: (2007)

CARS microscopy for the visualization of micrometer-sized iron oxide MRI contrast agents in living cells
por: Rago, Gianluca, et al.
Publicado: (2011)

Iron Oxide as an MRI Contrast Agent for Cell Tracking
por: Korchinski, Daniel J., et al.
Publicado: (2015)

Preparation and evaluation of LA-PEG-SPION, a targeted MRI contrast agent for liver cancer
por: Xia, Lei, et al.
Publicado: (2022)

Magnetic Resonance Imaging of Human-Derived Amniotic Membrane Stem Cells Using PEGylated Superparamagnetic Iron Oxide Nanoparticles
por: Naseroleslami, Maryam, et al.
Publicado: (2016)

Cyclodextrin-Appended Superparamagnetic Iron Oxide Nanoparticles as Cholesterol-Mopping Agents
por: Puglisi, Antonino, et al.
Publicado: (2021)

Folate-targeted polymeric micelles loaded with ultrasmall superparamagnetic iron oxide: combined small size and high MRI sensitivity
por: Hong, Guo-bin, et al.
Publicado: (2012)

Hollow carbon nanobubbles: monocrystalline MOF nanobubbles and their pyrolysis
por: Zhang, Wei, et al.
Publicado: (2017)

Mechanical instability of monocrystalline and polycrystalline methane hydrates
por: Wu, Jianyang, et al.
Publicado: (2015)

Neural Induction Potential and MRI of ADSCs Labeled Cationic Superparamagnetic Iron Oxide Nanoparticle In Vitro
por: Ma, Weiqiong, et al.
Publicado: (2018)

Cleavable PEGylation: a strategy for overcoming the “PEG dilemma” in efficient drug delivery
por: Fang, Yan, et al.
Publicado: (2017)

Large T(1) contrast enhancement using superparamagnetic nanoparticles in ultra-low field MRI
por: Yin, Xiaolu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_q19na0b3rsivgcc770lgdrftac